Jindrich Cinatl

InstitutionKlinikum der Goethe-Universität
AddressGermany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 5 publications in July 2021
    All Publications
    Bar chart showing 257 publications over 27 distinct years, with a maximum of 22 publications in 2009
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reus P, Schneider AK, Ulshöfer T, Henke M, Bojkova D, Cinatl J, Ciesek S, Geisslinger G, Laux V, Grättinger M, Gribbon P, Schiffmann S. Characterization of ACE Inhibitors and AT1R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model. Life (Basel). 2021 Aug 10; 11(8). PMID: 34440554.
      Citations:    
    2. Plenzig S, Holz F, Bojkova D, Kettner M, Cinatl J, Verhoff MA, Birngruber CG, Ciesek S, Rabenau HF. Detection and infectivity of SARS-CoV-2 in exhumated corpses. Int J Legal Med. 2021 Nov; 135(6):2531-2536. PMID: 34302215.
      Citations: 2     Fields:    Translation:Humans
    3. Armstrong LA, Lange SM, Dee Cesare V, Matthews SP, Nirujogi RS, Cole I, Hope A, Cunningham F, Toth R, Mukherjee R, Bojkova D, Gruber F, Gray D, Wyatt PG, Cinatl J, Dikic I, Davies P, Kulathu Y. Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. PLoS One. 2021; 16(7):e0253364. PMID: 34270554.
      Citations: 4     Fields:    Translation:HumansCells
    4. Wagner JUG, Bojkova D, Shumliakivska M, Luxán G, Nicin L, Aslan GS, Milting H, Kandler JD, Dendorfer A, Heumueller AW, Fleming I, Bibli SI, Jakobi T, Dieterich C, Zeiher AM, Ciesek S, Cinatl J, Dimmeler S. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol. 2021 07 05; 116(1):42. PMID: 34224022.
      Citations: 3     Fields:    Translation:HumansCells
    5. Van Damme E, De Meyer S, Bojkova D, Ciesek S, Cinatl J, De Jonghe S, Jochmans D, Leyssen P, Buyck C, Neyts J, Van Loock M. In vitro activity of itraconazole against SARS-CoV-2. J Med Virol. 2021 Jul; 93(7):4454-4460. PMID: 33666253.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    6. Widera M, Westhaus S, Rabenau HF, Hoehl S, Bojkova D, Cinatl J, Ciesek S. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings. Med Microbiol Immunol. 2021 Aug; 210(4):235-244. PMID: 34196781.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    7. Mukherjee R, Bhattacharya A, Bojkova D, Mehdipour AR, Shin D, Khan KS, Hei-Yin Cheung H, Wong KB, Ng WL, Cinatl J, Geurink PP, van der Heden van Noort GJ, Rajalingam K, Ciesek S, Hummer G, Dikic I. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection. J Biol Chem. 2021 08; 297(2):100925. PMID: 34214498.
      Citations: 6     Fields:    Translation:HumansCells
    8. Schultz B, Zaliani A, Ebeling C, Reinshagen J, Bojkova D, Lage-Rupprecht V, Karki R, Lukassen S, Gadiya Y, Ravindra NG, Das S, Baksi S, Domingo-Fernández D, Lentzen M, Strivens M, Raschka T, Cinatl J, DeLong LN, Gribbon P, Geisslinger G, Ciesek S, van Dijk D, Gardner S, Kodamullil AT, Fröhlich H, Peitsch M, Jacobs M, Hoeng J, Eils R, Claussen C, Hofmann-Apitius M. A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization. Sci Rep. 2021 05 26; 11(1):11049. PMID: 34040048.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Plenzig S, Bojkova D, Held H, Berger A, Holz F, Cinatl J, Gradhand E, Kettner M, Pfeiffer A, Verhoff MA, Ciesek S. Infectivity of deceased COVID-19 patients. Int J Legal Med. 2021 Sep; 135(5):2055-2060. PMID: 33665704.
      Citations: 4     Fields:    Translation:Humans
    10. Ellinger B, Bojkova D, Zaliani A, Cinatl J, Claussen C, Westhaus S, Keminer O, Reinshagen J, Kuzikov M, Wolf M, Geisslinger G, Gribbon P, Ciesek S. A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection. Sci Data. 2021 02 26; 8(1):70. PMID: 33637768.
      Citations: 10     Fields:    Translation:HumansCells
    11. Bojkova D, McGreig JE, McLaughlin KM, Masterson SG, Antczak M, Widera M, Krähling V, Ciesek S, Wass MN, Michaelis M, Cinatl J. Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour. Bioinformatics. 2021 Feb 09. PMID: 33560365.
      Citations: 3     Fields:    
    12. Bojkova D, Wagner JUG, Shumliakivska M, Aslan GS, Saleem U, Hansen A, Luxán G, Günther S, Pham MD, Krishnan J, Harter PN, Ermel UH, Frangakis AS, Milting H, Zeiher AM, Klingel K, Cinatl J, Dendorfer A, Eschenhagen T, Tschöpe C, Ciesek S, Dimmeler S. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res. 2020 12 01; 116(14):2207-2215. PMID: 32966582.
      Citations: 61     Fields:    Translation:HumansCells
    13. Bojkova D, Bechtel M, McLaughlin KM, McGreig JE, Klann K, Bellinghausen C, Rohde G, Jonigk D, Braubach P, Ciesek S, Münch C, Wass MN, Michaelis M, Cinatl J. Aprotinin Inhibits SARS-CoV-2 Replication. Cells. 2020 10 30; 9(11). PMID: 33143316.
      Citations: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    14. Schäfer R, Spohn G, Bechtel M, Bojkova D, Baer PC, Kuçi S, Seifried E, Ciesek S, Cinatl J. Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells. Stem Cell Reports. 2021 03 09; 16(3):419-427. PMID: 32950067.
      Citations: 16     Fields:    Translation:HumansCells
    15. Klann K, Bojkova D, Tascher G, Ciesek S, Münch C, Cinatl J. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication. Mol Cell. 2020 10 01; 80(1):164-174.e4. PMID: 32877642.
      Citations: 51     Fields:    Translation:HumansCells
    16. McLaughlin KM, Bechtel M, Bojkova D, Münch C, Ciesek S, Wass MN, Michaelis M, Cinatl J. COVID-19-Related Coagulopathy-Is Transferrin a Missing Link? Diagnostics (Basel). 2020 Jul 30; 10(8). PMID: 32751741.
      Citations: 9     
    17. Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, Schulz L, Widera M, Mehdipour AR, Tascher G, Geurink PP, Wilhelm A, van der Heden van Noort GJ, Ovaa H, Müller S, Knobeloch KP, Rajalingam K, Schulman BA, Cinatl J, Hummer G, Ciesek S, Dikic I. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020 11; 587(7835):657-662. PMID: 32726803.
      Citations: 187     Fields:    Translation:HumansAnimalsCells
    18. Toptan T, Hoehl S, Westhaus S, Bojkova D, Berger A, Rotter B, Hoffmeier K, Cinatl J, Ciesek S, Widera M. Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs. Int J Mol Sci. 2020 Jun 20; 21(12). PMID: 32575728.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    19. De Meyer S, Bojkova D, Cinatl J, Van Damme E, Buyck C, Van Loock M, Woodfall B, Ciesek S. Lack of antiviral activity of darunavir against SARS-CoV-2. Int J Infect Dis. 2020 Aug; 97:7-10. PMID: 32479865.
      Citations: 49     Fields:    Translation:HumansCellsPHPublic Health
    20. Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, Cinatl J, Münch C. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020 07; 583(7816):469-472. PMID: 32408336.
      Citations: 281     Fields:    Translation:HumansCellsPHPublic Health
    21. Hoehl S, Rabenau H, Berger A, Kortenbusch M, Cinatl J, Bojkova D, Behrens P, Böddinghaus B, Götsch U, Naujoks F, Neumann P, Schork J, Tiarks-Jungk P, Walczok A, Eickmann M, Vehreschild MJGT, Kann G, Wolf T, Gottschalk R, Ciesek S. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020 03 26; 382(13):1278-1280. PMID: 32069388.
      Citations: 218     Fields:    Translation:HumansCellsPHPublic Health
    22. Michaelis M, Doerr HW, Cinatl J. Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011 Mar 15; 18(5):384-6. PMID: 21036571.
      Citations: 40     Fields:    Translation:HumansAnimalsCells
    23. Chen CJ, Michaelis M, Hsu HK, Tsai CC, Yang KD, Wu YC, Cinatl J, Doerr HW. Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J Ethnopharmacol. 2008 Oct 30; 120(1):108-11. PMID: 18762235.
      Citations: 47     Fields:    Translation:AnimalsCells
    24. Loizzo MR, Saab AM, Tundis R, Statti GA, Menichini F, Lampronti I, Gambari R, Cinatl J, Doerr HW. Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem Biodivers. 2008 Mar; 5(3):461-70. PMID: 18357554.
      Citations: 44     Fields:    Translation:AnimalsCells
    25. Kuate S, Cinatl J, Doerr HW, Uberla K. Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies. Virology. 2007 May 25; 362(1):26-37. PMID: 17258782.
      Citations: 67     Fields:    Translation:HumansAnimalsCells
    26. Zhang HZ, Zhang H, Kemnitzer W, Tseng B, Cinatl J, Michaelis M, Doerr HW, Cai SX. Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. J Med Chem. 2006 Feb 09; 49(3):1198-201. PMID: 16451084.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    27. Rabenau HF, Kampf G, Cinatl J, Doerr HW. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect. 2005 Oct; 61(2):107-11. PMID: 15923059.
      Citations: 101     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    28. Cinatl J, Michaelis M, Hoever G, Preiser W, Doerr HW. Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res. 2005 Jun; 66(2-3):81-97. PMID: 15878786.
      Citations: 29     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    29. Rabenau HF, Biesert L, Schmidt T, Bauer G, Cinatl J, Doerr HW. SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation. Biologicals. 2005 Jun; 33(2):95-9. PMID: 15939287.
      Citations: 16     Fields:    Translation:HumansCells
    30. Hoever G, Baltina L, Michaelis M, Kondratenko R, Baltina L, Tolstikov GA, Doerr HW, Cinatl J. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem. 2005 Feb 24; 48(4):1256-9. PMID: 15715493.
      Citations: 121     Fields:    Translation:AnimalsCells
    31. Cinatl J, Michaelis M, Morgenstern B, Doerr HW. High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells. Int J Mol Med. 2005 Feb; 15(2):323-7. PMID: 15647850.
      Citations: 19     Fields:    Translation:AnimalsCells
    32. Morgenstern B, Michaelis M, Baer PC, Doerr HW, Cinatl J. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochem Biophys Res Commun. 2005 Jan 28; 326(4):905-8. PMID: 15607755.
      Citations: 110     Fields:    Translation:HumansAnimalsCells
    33. Rabenau HF, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr HW. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005 Jan; 194(1-2):1-6. PMID: 15118911.
      Citations: 202     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    34. Giroglou T, Cinatl J, Rabenau H, Drosten C, Schwalbe H, Doerr HW, von Laer D. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol. 2004 Sep; 78(17):9007-15. PMID: 15308697.
      Citations: 58     Fields:    Translation:HumansAnimalsCells
    35. Cinatl J, Hoever G, Morgenstern B, Preiser W, Vogel JU, Hofmann WK, Bauer G, Michaelis M, Rabenau HF, Doerr HW. Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell Mol Life Sci. 2004 Aug; 61(16):2100-12. PMID: 15316659.
      Citations: 32     Fields:    Translation:HumansCells
    36. Yamamoto N, Yang R, Yoshinaka Y, Amari S, Nakano T, Cinatl J, Rabenau H, Doerr HW, Hunsmann G, Otaka A, Tamamura H, Fujii N, Yamamoto N. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun. 2004 Jun 04; 318(3):719-25. PMID: 15144898.
      Citations: 127     Fields:    Translation:AnimalsCells
    37. Cinatl J, Michaelis M, Scholz M, Doerr HW. Role of interferons in the treatment of severe acute respiratory syndrome. Expert Opin Biol Ther. 2004 Jun; 4(6):827-36. PMID: 15174965.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    38. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet. 2003 Jul 26; 362(9380):293-4. PMID: 12892961.
      Citations: 197     Fields:    Translation:HumansCells
    39. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003 Jun 14; 361(9374):2045-6. PMID: 12814717.
      Citations: 342     Fields:    Translation:HumansAnimalsCells
    40. Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguière AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003 May 15; 348(20):1967-76. PMID: 12690091.
      Citations: 1705     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Cinatl's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (363)
    Explore
    _
    Co-Authors (188)
    Explore
    _
    Similar People (60)
    Explore
    _